Betablocker therapy and risk of chronic obstructive pulmonary disease – a Danish nationwide study of 1.4 million individuals

A. Nielsen (Køge, Denmark), L. Pedersen (Aarhus, Denmark), B. Sode (Copenhagen, Denmark), M. Dahl (Køge, Denmark)

Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Session: COPD treatment: cardiovascular, oxygen and vaccination studies
Session type: Thematic Poster
Number: 2459
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Nielsen (Køge, Denmark), L. Pedersen (Aarhus, Denmark), B. Sode (Copenhagen, Denmark), M. Dahl (Køge, Denmark). Betablocker therapy and risk of chronic obstructive pulmonary disease – a Danish nationwide study of 1.4 million individuals. 2459

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The association of diuretics treatment with hospitalization rates of patients with chronic obstructive pulmonary disease and pulmonary hypertension: a population-based study
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


Impact of chronic obstructive pulmonary disease on specific-cause of mortality: a national cohort study
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Year: 2019




Prospective cohort study of the alternate healthy eating index-2010 and risk of chronic obstructive pulmonary disease in US women and men
Source: Annual Congress 2013 –Environment and lifestyle: associations with respiratory disease
Year: 2013


Depressive symptoms among patients with chronic obstructive pulmonary disease before and after smoking cessation – a Danish nationwide cohort study of 21 184 patients
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020

National epidemiological study of smoking cessation in danish patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – The role of health care systems in treating tobacco dependence
Year: 2020


Venous thromboembolic (VTE) disease in people with chronic obstructive pulmonary disease (COPD): A matched case-control study
Source: International Congress 2015 – New observations in respiratory epidemiology
Year: 2015


Comorbidities in chronic obstructive pulmonary disease: a nation-wide twin study
Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD
Year: 2018



Association between chronic obstructive pulmonary disease and endometriosis: a population-based cohort study
Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases
Year: 2020

Spirometries in patients at a high risk of developing chronic obstructive pulmonary disease in general practices in Switzerland
Source: Eur Respir J 2007; 30: Suppl. 51, 777s
Year: 2007

Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Lifetime occupational history and chronic obstructive pulmonary disease in a population-based study
Source: Virtual Congress 2020 – Occupational lung diseases
Year: 2020


Socioeconomic position and use of drugs in chronic obstructive pulmonary disease (COPD): A population-based cohort study in Rome, Italy
Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD
Year: 2011


Nomogram for patients with exacerbation in the general practitioners based Swiss chronic obstructive pulmonary disease cohort
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021


Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005


An observational study of risk factors for hospitalization of chronic obstructive pulmonary disease exacerbation and their outcome
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


Economic evaluation of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: A retrospective, case-controlled, cost of illness study
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010


The incidence of chronic thromboembolic pulmonary hypertension (CTEPH): a 25-year population-based study
Source: Eur Respir J 2003; 22: Suppl. 45, 462s
Year: 2003

The prevalence of chronic obstructive pulmonary disease (COPD) in individuals with diabetes, hypertension, asthma, or mood/anxiety disorders: A Canadian population study
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012


Impact of steroid therapy on exacerbation of chronic obstructive pulmonary disease with community-onset pneumonia: a multicenter retrospective cohort study
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020


The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients.
Source: Eur Respir J 2002; 20: 1617
Year: 2002